10.1002/anie.201802822
Angewandte Chemie International Edition
COMMUNICATION
1177; d) J. W. Checco, S. H. Gellman, Curr. Opin. Struct. Biol. 2016, 39,
96–105.
On the basis of the results obtained for the homo-oligomers,
hetero-trimer 22 (Figure 5, right) was expected to favour a
conformation curved at the pyrimidine and linear at the pyridazine
linkers along its backbone. This was found to be the case, with
the observation of several key nOe correlations – namely H3↔H11,
H7↔H13, H8↔H13 and H13↔H15 – indicating a strong preference
for the predicted conformations about both N-Cpyrimidine bonds (as
shown). Similarly, the absence of H16↔H20 and H21↔H24
correlations is consistent with the illustrated conformation around
both N-Cpyridazine bonds. Foldamers 20 and 21 displayed
analogous spectral features, indicating that they adopt the
[7]
a) J. Zhu, R. D. Parra, H. Zeng, E. Skrzypczak-Jankun, X. C. Zeng, B.
Gong, J. Am. Chem. Soc. 2000, 122, 4219–4220; b) B. Gong, Chem. Eur.
J. 2001, 7, 4336–4342; c) B. Gong, H. Zeng, J. Zhu, L. Yua, Y. Han, S.
Cheng, M. Furukawa, R. D. Parra, A. Y. Kovalevsky, J. L. Mills, E.
Skrzypczak-Jankun, S. Martinovic, R. D. Smith, C. Zheng, T. Szyperski,
X. C. Zeng, Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 11583–11588; d)
Curr. Org. Chem. 2003, 7, 1649-1659; e) Chem. Commun. 2012, 48,
12142-12158; f) Org. Lett. 2017, 19, 2666-2669.
[8]
[9]
a) J. Garric, J.-M. Léger, I. Huc, Angew. Chem. Int. Ed. 2005, 44, 1954–
1958; b) H. Jiang, J.-M. Léger, I. Huc, J. Am. Chem. Soc. 2003, 125,
3448–3449; c) for recent incorporation of foldamers into ribosomal
synthesis see J. M. Rogers, S. Kwon, S. J. Dawson, P. K. Mandal, H.
Suga, I. Huc, Nature Chem. 2018, 10, 405-412.
dipole-opposed conformations depicted in Figure
5 (see
supporting information). This confirms that the design strategy
described herein allows the construction of bespoke oligomers
with predictable, non-repetitive conformations.
M. Burns, S. Essafi, J. R. Bame, S. P. Bull, M. P. Webster, S. Balieu, J.
W. Dale, C. P. Butts, J. N. Harvey, V. K. Aggarwal, Nature 2014, 513,
183–188.
In conclusion, we have developed a chiral amino alcohol-derived
foldamer backbone incorporating pyrimidine, pyridazine and
pyrazine linkers, synthesized primarily through an iterative
deprotection-coupling sequence. These foldamers reliably adopt
conformations which can be predicted using a simple dipolar
repulsion argument, even in highly polar solvents. As well as
giving control of the overall backbone shape, this permits the
projection of side-chains from multiple faces of the foldamer by
choice of linker, enabling rapid and programmable exploration of
macromolecular conformational space.
[10] For discussion of conformational control in acyclic molecules with an
emphasis on hydrocarbons, see R. W. Hoffmann, Angew. Chem. Int. Ed.
2000, 39, 2054–2070 and references therein.
[11] M. Barboiu, A. M. Stadler, J. M. Lehn, Angew. Chem. Int. Ed. 2016, 55,
4130–4154.
[12] a) G. S. Hanan, J.-M. Lehn, N. Kyritsakas, J. Fischer, J. Chem. Soc.
Chem. Commun. 1995, 765-766; b) M. Ohkita, J.-M. Lehn, G. Baum, D.
Fenske, Chem. Eur. J. 1999, 5, 3471–3481; c) D. M. Bassani, J.-M. Lehn,
G. Baum, D. Fenske, Angew. Chem. Int. Ed. 1997, 36, 1845–1847; d) L.
A. Cuccia, J.-M. Lehn, J.-C. Homo, M. Schmutz, Angew. Chem. Int. Ed.
2000, 39, 233-237; e) L. A. Cuccia, E. Ruiz, J.-M. Lehn, J.-C. Homo, M.
Schmutz, Chem. Eur. J. 2002, 8, 3448-3457.
[13] M. S. Betson, J. Clayden, H. K. Lam, M. Helliwell, Angew. Chem. Int. Ed.
2005, 44, 1241–1244.
Acknowledgements
[14] J. Clayden, A. Lund, L. Vallverdú, M. Helliwell, Nature 2004, 431, 966–
971.
We acknowledge financial support from the Royal Society
(RG160614, PCK), the EPSRC (EP/R021481/1, PCK) and
Queen’s University Belfast (start-up grant, PCK), and thank
Professor Eric V. Anslyn for helpful discussions in the preparation
of this manuscript.
[15] a) A. B. Smith III, A. K. Charnley, R. Hirschmann, Acc. Chem. Res. 2011,
44, 180–193; b) V. Azzarito, K. Long, N. S. Murphy, A. J. Wilson, Nat.
Chem. 2013, 5, 161–173; c) S. Fahs, Y. Patil-Sen, T. J. Snape,
ChemBioChem 2015, 16, 1840–1853; d) E. A. German, J. E. Ross, P. C.
Knipe, M. F. Don, S. Thompson, A. D. Hamilton, Angew. Chem. Int. Ed.
2015, 54, 2649–2652; e) T. Yamashita, P. C. Knipe, N. Busschaert, S.
Thompson, A. D. Hamilton, Chem. Eur. J. 2015, 21, 14699–14702.
[16] a) R. P. Cheng, W. F. DeGrado, J. Am. Chem. Soc. 2002, 124, 11564–
11565; b) J. L. Price, E. B. Hadley, J. D. Steinkruger, S. H. Gellman,
Angew. Chem. Int. Ed. 2010, 49, 368–371; c) N. Delsuc, S. Massip, J.-
M. Léger, B. Kauffmann, I. Huc, J. Am. Chem. Soc. 2011, 133, 3165–
3172.; d) J. J. L. M. Cornelissen, J. J. M. Donners, R. de Gelder, W.
Sander Graswinckel, G. A. Metselaar, A. E. Rowan, N. A. J. M.
Sommerdijk, R. J. M. Nolte, Science 2001, 293, 676–680; e) G. W. Collie,
K. Pulka-Ziach, C. M. Lombardo, J. Fremaux, F. Rosu, M. Decossas, L.
Mauran, O. Lambert, V. Gabelica, C. D. Mackereth, G. Guichard, Nat.
Chem. 2015, 7, 871–878.
Keywords: foldamers • oligomerization • conformational
analysis • protein-protein interactions
[1]
[2]
C. B. Anfinsen, Science 1973, 181, 223–230.
K. A. Dill, S. B. Ozkan, M. S. Shell, T. R. Weikl, Annu. Rev. Biophys.
2008, 37, 289–316.
[3]
For reviews see: a) S. H. Gellman, Acc. Chem. Res. 1998, 31, 173–180;
b) C. M. Goodman, S. Choi, S. Shandler, W. F. DeGrado, Nat. Chem.
Biol. 2007, 3, 252–262; c) D. J. Hill, M. J. Mio, R. B. Prince, T. S. Hughes,
J. S. Moore, Chem. Rev. 2001, 101, 3893–4011; d) S. Hecht, I. Huc,
Eds. , Foldamers: Structure, Properties and Applications, Wiley-VCH
Verlag GmbH & Co. KGaA, Weinheim, Germany, 2007; e) G. Guichard,
I. Huc, Chem. Commun. 2011, 47, 5933–5941; f) D.-W. Zhang, X. Zhao,
J.-L. Hou, Z.-T. Li, Chem. Rev. 2012, 112, 5271–5316.; g) I. Saraogi, A.
D. Hamilton, Chem. Soc. Rev. 2009, 38, 1726–1743; h) T. A. Martinek,
F. Fülöp, Chem. Soc. Rev. 2012, 41, 687–702.
[17] a) K. L. George, W. S. Horne, J. Am. Chem. Soc. 2017, 139, 7931–7938;
b) Z. E. Reinert, G. A. Lengyel, W. S. Horne, J. Am. Chem. Soc. 2013,
135, 12528–12531.
[18] T. W. Craven, R. Bonneau, K. Kirshenbaum, ChemBioChem 2016, 17,
1824–1828.
[19] A. Lamouroux, L. Sebaoun, B. Wicher, B. Kauffmann, Y. Ferrand, V.
Maurizot, I. Huc, J. Am. Chem. Soc. 2017, 139, 14668–14675.
[20] W. S. Horne, S. H. Gellman, Acc. Chem. Res. 2008, 41, 1399–1408.
[21] P. C. Knipe, S. Thompson, A. D. Hamilton, Chem. Commun. 2016, 52,
6521–6524.
[4]
a) G. Maayan, M. D. Ward, K. Kirshenbaum, Proc. Natl. Acad. Sci. U. S.
A. 2009, 106, 13679–13684; b) M. M. Müller, M. A. Windsor, W. C.
Pomerantz, S. H. Gellman, D. Hilvert, Angew. Chem. Int. Ed. 2009, 48,
922–925; c) C. Mayer, M. M. Müller, S. H. Gellman, D. Hilvert, Angew.
Chem. Int. Ed. 2014, 53, 6978–6981.
[22] CCDC 1824641 (3), 1824637 (4), 1824639 (5), 1824642 (10), 1824638
(11), 1825640 (12) contain the supplementary crystallographic data for
this paper. These data are provided free of charge by The Cambridge
Crystallographic Data Centre.
[5]
[6]
a) F. G. A. Lister, B. A. F. Le Bailly, S. J. Webb, J. Clayden, Nat. Chem.
2017, 9, 420–425; b) B. A. F. Le Bailly, J. Clayden, Chem. Commun.
2016, 52, 4852–4863.
a) O. Keskin, N. Tuncbag, A. Gursoy, Chem. Rev. 2016, 116, 4884–
4909; b) G. Zinzalla, D. E. Thurston, Future Med. Chem. 2009, 1, 65–93;
c) I. M. Mándity, F. Fülöp, Expert Opin. Drug Discov. 2015, 10, 1163–
[23] We use the terms monomer, dimer, trimer etc. to indicate the number of
imidazolidin-2-one rings present within a given molecule.
[24] The sum of H3↔H6 and H3↔H6’, relative to the sum of H12↔H15 and
H12↔H15’ cross-peak integrals.
This article is protected by copyright. All rights reserved.